AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Chronic Liver Disease Condition and Transplant Prognosis Assisted by Eye Biological Parameters

Recruitingn/aAges 18 Years - anyAllZhongshan Ophthalmic Center, Sun Yat-sen Universi…
💬

In plain words

What the trial is, and whether it could suit you

This study investigates the correlation between ocular biological characteristics and overall conditions before and after liver transplantation by collecting ocular biological characteristics. Explore whether it is possible to construct a clinical prediction model for liver transplantation by incorporating ocular biometric features, in order to optimize disease management before and after liver transplantation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age greater than or equal to 18 years old; 2. Late stage liver disease patients waiting for liver transplantation treatment, as well as patients with varying degrees of cirrhosis; 3. Can collect complete basic demographic information, liver function blood test indicators, liver pathology and imaging examination results; 4. Can cooperate with eye OCT, OCTA and other examinations, and obtain qualified examination parameters; 5. Voluntarily follow the clinical trial protocol and sign the informed consent form. Exclusion Criteria: 1. History of other organ transplant surgeries; 2. History of intraocular laser treatment, medication injection, and surgery; 3. History of high myopia, glaucoma, and retinal choroidal related eye diseases; 4. History of major systemic diseases other than liver disease; 5. Individuals whose overall body and eye conditions cannot cooperate with eye examinations.
💊

What it tests

  • Ophthalmic examination
  • General Condition Examination
📍

Where

1 site
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy